Case report: JAKi and TNFi dual therapy is a potential treatment strategy for difficult-to-treat rheumatoid arthritis

Case report: JAKi and TNFi dual therapy is a potential treatment strategy for difficult-to-treat rheumatoid arthritis

Rheumatoid arthritis (RA) is a heterogeneous chronic disease. RA patients should start disease modifying anti-rheumatic drugs (DMARDs) therapy immediately after diagnosis. If first-line treatment with conventional synthetic DMARDs does not relieve the disease, biology and targeted synthetic DMARDs a...

Full description

Bibliographic Details
Main Authors: Jing-Wen Chen, Wen-Shuang Zhang, Chang-Song Lin, Qiang Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
tofacitinib
adalimumab
JAKi
TNFi
dual therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1074329/full

Similar Items

Similar Items